| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2088682 | Journal of Immunological Methods | 2010 | 6 Pages |
Abstract
We currently use a rat model in our investigations into human rheumatic heart disease (RHD). This model traditionally involves footpad immunization with antigen emulsified in complete Freund's adjuvant (CFA). Trials to find an alternative adjuvant to CFA which produced a Th1 type response in the rats resulting in carditis were unsuccessful. However, hock immunization was found to produce the desired valvular pathology without the adverse inflammatory side-effects associated with CFA. We therefore consider the hock an ideal site for immunization, particularly when using CFA.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
D. Gorton, S. Blyth, J.G. Gorton, B. Govan, N. Ketheesan,